BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial

The replication of the previous finding of increased serum BDNF levels after cognitive remediation in clinically stable individuals with schizophrenia was not achieved. However, our data indicated that genetic variability may be mediating serum BDNF activity in the context of CRT.